Plasmaaustausch bei steroidresistenten Multiple-Sklerose-Schüben : Klinische Erfahrungen an 16 Patienten

作者: A. Chan , R. Gold , S. Schilling , R. A. Linker , F. B. König

DOI: 10.1007/S00115-005-2019-1

关键词: PlasmapheresisOptic neuritisPediatricsApheresisMedicineNeurosurgeryTherapeutic effectDiseaseNeurologyMultiple sclerosis

摘要: Patients with severe multiple sclerosis (MS) relapses which do not respond sufficiently to corticosteroids can undergo escalating immunotherapy plasma exchange. We review the course of 14 apheresis cycles in 13 adult patients and three pediatric cases from our center between 2004 2005. Nine were due optic neuritis, five had experienced clinically isolated syndromes, two suffered Devic's disease. Of patients, 71% good or very outcome. The mean time point improvement was after third plasmapheresis session, early initiation exchange therapy (within 1 month begin relapse) associated better In MS, showed clear improvement. These data argue for a therapeutic effect if performed adequate indication.

参考文章(12)
Multiple Sclerosis Therapy Consensus Group, P Rieckmann, KV Toyka, None, Escalating immunotherapy of multiple sclerosis--new aspects and practical application. Journal of Neurology. ,vol. 251, pp. 1329- 1339 ,(2004) , 10.1007/S00415-004-0537-6
Martin Stangel, Hans-Peter Hartung, Peter Marx, Ralf Gold, Intravenous immunoglobulin treatment of neurological autoimmune diseases Journal of the Neurological Sciences. ,vol. 153, pp. 203- 214 ,(1998) , 10.1016/S0022-510X(97)00292-X
I. Simón, J. Vendrell, C. Gutiérrez, J.M. Fernández-Real, I. Vendrell, Ll. Gallart, R. Fontova, C. Richart, Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus. Hormone Research in Paediatrics. ,vol. 58, pp. 143- 149 ,(2002) , 10.1159/000064490
K. Ruprecht, E. Klinker, T. Dintelmann, P. Rieckmann, R. Gold, Plasma exchange for severe optic neuritis: treatment of 10 patients. Neurology. ,vol. 63, pp. 1081- 1083 ,(2004) , 10.1212/01.WNL.0000138437.99046.6B
Peter Rieckmann, Improving MS patient care. Journal of Neurology. ,vol. 251, ,(2004) , 10.1007/S00415-004-1511-Z
M. Keegan, A. A. Pineda, R. L. McClelland, C. H. Darby, M. Rodriguez, B. G. Weinshenker, Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology. ,vol. 58, pp. 143- 146 ,(2002) , 10.1212/WNL.58.1.143
Brian G. Weinshenker, Peter C. O'Brien, Tanya M. Petterson, John H. Noseworthy, Claudia F. Lucchinetti, David W. Dodick, Alvaro A. Pineda, Lorna N. Stevens, Moses Rodriguez, A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Annals of Neurology. ,vol. 46, pp. 878- 886 ,(1999) , 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q
N M Milligan, R Newcombe, D A Compston, A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 50, pp. 511- 516 ,(1987) , 10.1136/JNNP.50.5.511
Mark Keegan, Fatima König, Robyn McClelland, Wolfgang Brück, Yazmín Morales, Andreas Bitsch, Hillel Panitch, Hans Lassmann, Brian Weinshenker, Moses Rodriguez, Joseph Parisi, Claudia F Lucchinetti, Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange The Lancet. ,vol. 366, pp. 579- 582 ,(2005) , 10.1016/S0140-6736(05)67102-4
Wolfgang Brück, Katrin Neubert, Thomas Berger, Joerg R Weber, Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination--possible markers for an antibody-mediated process. Multiple Sclerosis Journal. ,vol. 7, pp. 173- 177 ,(2001) , 10.1177/135245850100700307